Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands

被引:19
作者
Moussouras, Natasha A. [1 ]
Getschman, Anthony E. [2 ]
Lackner, Emily R. [3 ]
Veldkamp, Christopher T. [3 ]
Dwinell, Michael B. [1 ]
Volkman, Brian F. [2 ]
机构
[1] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
[3] Univ Wisconsin Whitewater, Dept Chem, Whitewater, WI 53190 USA
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 09期
基金
美国国家卫生研究院;
关键词
CXCL5; CXCL8; CXCR1; CXCR2; sulfotyrosine; post-translational modification; chemokines; NMR; GRANULOCYTE CHEMOTACTIC PROTEIN-2; NEUTROPHIL-ACTIVATING PEPTIDE-78; SOLUTION NMR CHARACTERIZATION; TYROSINE SULFATION SITES; EPITHELIAL-CELLS; DIMER BINDING; CC-CHEMOKINE; HOST-DEFENSE; HOT-SPOTS; RECEPTOR;
D O I
10.3390/ijms18091894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyrosine sulfation, a post-translational modification found on many chemokine receptors, typically increases receptor affinity for the chemokine ligand. A previous bioinformatics analysis suggested that a sulfotyrosine (sY)-binding site on the surface of the chemokine CXCL12 may be conserved throughout the chemokine family. However, the extent to which receptor tyrosine sulfation contributes to chemokine binding has been examined in only a few instances. Computational solvent mapping correctly identified the conserved sulfotyrosine-binding sites on CXCL12 and CCL21 detected by nuclear magnetic resonance (NMR) spectroscopy, demonstrating its utility for hot spot analysis in the chemokine family. In this study, we analyzed five chemokines that bind to CXCR2, a subset of which also bind to CXCR1, to identify hot spots that could participate in receptor binding. A cleft containing the predicted sulfotyrosine-binding pocket was identified as a principal hot spot for ligand binding on the structures of CXCL1, CXCL2, CXCL7, and CXCL8, but not CXCL5. Sulfotyrosine titrations monitored via NMR spectroscopy showed specific binding to CXCL8, but not to CXCL5, which is consistent with the predictions from the computational solvent mapping. The lack of CXCL5-sulfotyrosine interaction and the presence of CXCL8-sulfotyrosine binding suggests a role for receptor post-translational modifications regulating ligand selectivity.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists
    Chao, Jianhua
    Taveras, Arthur G.
    Chao, Jianping
    Aki, Cynthia
    Dwyer, Michael
    Yu, Younong
    Purakkattle, Biju
    Rindgen, Diane
    Jakway, James
    Hipkin, William
    Fosetta, James
    Fan, Xuedong
    Lundell, Daniel
    Fine, Jay
    Minnicozzi, Michael
    Phillips, Jonathan
    Merritt, J. Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3778 - 3783
  • [32] The antagonist of CXCR1 and CXCR2 protects db/db mice from metabolic diseases through modulating inflammation
    Cui, Siyuan
    Qiao, Lu
    Yu, Shanshan
    Men, Lili
    Li, Yu
    Li, Fang
    Du, Jianling
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2019, 317 (06): : E1205 - E1217
  • [33] Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis
    Singh, Seema
    Sadanandam, Anguraj
    Nannuru, Kalyan C.
    Varney, Michelle L.
    Mayer-Ezell, Rosemary
    Bond, Richard
    Singh, Rakesh K.
    CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2380 - 2386
  • [34] Chemokine receptor CXCR2: Physiology regulator and neuroinflammation controller?
    Veenstra, Mike
    Ransohoff, Richard M.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 246 (1-2) : 1 - 9
  • [35] CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation
    Singh, Seema
    Wu, Sheng
    Varney, Michelle
    Singh, Ajay P.
    Singh, Rakesh K.
    MICROVASCULAR RESEARCH, 2011, 82 (03) : 318 - 325
  • [36] Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion
    Singh, Seema
    Sadanandam, Anguraj
    Varney, Michelle L.
    Nannuru, Kalyan C.
    Singh, Rakesh K.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (02) : 328 - 336
  • [37] CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration
    Zeng, Ye
    Sun, Hu-Rong
    Yu, Chang
    Lai, Yi
    Liu, Xiao-Jing
    Wu, Jiang
    Chen, Huai-Qing
    Liu, Xiao-Heng
    CYTOKINE, 2011, 53 (01) : 42 - 51
  • [38] Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease
    Leonard, Deborah A.
    Merhige, Michael E.
    Williams, Brent A.
    Greene, Robert S.
    CORONARY ARTERY DISEASE, 2011, 22 (07) : 491 - 496
  • [39] Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6
    Catusse, J
    Struyf, S
    Wuyts, A
    Weyler, M
    Loos, T
    Gijsbers, K
    Gouwy, M
    Proost, P
    Van Damme, J
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (10) : 1947 - 1955
  • [40] Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis
    Almasi, Shohreh
    Aliparasti, Mohammad Reza
    Farhoudi, Mehdi
    Babaloo, Zohreh
    Baradaran, Behzad
    Zamani, Fatemeh
    Sadeghi-Bazargani, Homayoun
    Mostafaei, Somaiyeh
    Hokmabadi, Elyar Sadeghi
    IMMUNOLOGICAL INVESTIGATIONS, 2013, 42 (08) : 737 - 748